title: Interaction with Mixed Micelles in the Intestine Attenuates the Permeation Enhancing Potential of Alkyl-Maltosides.
abstract: The purpose of the present study was to investigate the interaction of intestinal permeation enhancers with lipid and surfactant components present in the milieu of the small intestine. Maltosides of different chain lengths (decyl-, dodecyl-, and tetradecyl-maltoside; DM, DDM, TDM, respectively) were used as examples of nonionic, surfactant-like permeation enhancers, and their effect on the permeation of FD4 across Caco-2 monolayers was monitored. To mimic the environment of the small intestine, modified versions of fasted and fed state simulated intestinal fluid (FaSSIFmod, FeSSIFmod6.5, respectively) were used in addition to standard transport media (TM). Compared to the buffer control, 0.5 mM DDM led to a 200-fold permeation enhancement of FD4 in TM. However, this was dramatically decreased in FaSSIFmod, where a concentration of 5 mM DDM was necessary in order to elicit a moderate, 4-fold, permeation enhancement. Its capacity to promote permeation was diminished further when FeSSIFmod6.5 was employed. Even when cells were exposed to a concentration of 5 mM, no significant permeation enhancement of FD4 was observed. Analogous effects were observed in the case of DM and TDM, with slight deviations on account of differences in their critical micelle concentration (CMC). This observation was corroborated by calculating the amount of maltoside monomer versus micellar bound maltoside in FaSSIFmod and FeSSIFmod6.5, which demonstrated a reduced amount of free monomer in these fluids. To evaluate the in vivo significance of our findings, DDM solutions in TM, FaSSIFmod, and FeSSIFmod6.5 were used for closed intestinal loop studies in rats. Consistent with the results found in in vitro permeation studies, these investigations illustrated the overwhelming impact of sodium taurocholate/lecithin micelles on the permeation enhancing effect of DDM. While DDM led to a 20-fold increase in FD4 bioavailability when it was applied in TM, no significant permeation enhancement was seen in FaSSIFmod/FeSSIFmod6.5. Collectively, these investigations highlight the importance of using biorelevant media when evaluating the potency of permeation enhancers. In doing so, this ensures improved correlations between in vitro and in vivo studies and thus enables an early and more accurate assessment of promising permeation enhancers.
authors: †Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan.|‡Global Research, Novo Nordisk A/S, DK-2760 Måløv, Denmark.
authors: Kerstin
authors: K
authors: Gradauer
authors: †Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan.
authors: Ayano
authors: A
authors: Nishiumi
authors: †Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan.
authors: Kota
authors: K
authors: Unrinin
authors: †Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan.
authors: Haruki
authors: H
authors: Higashino
authors: †Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan.
authors: Makoto
authors: M
authors: Kataoka
authors: ‡Global Research, Novo Nordisk A/S, DK-2760 Måløv, Denmark.
authors: Betty L
authors: BL
authors: Pedersen
authors: ‡Global Research, Novo Nordisk A/S, DK-2760 Måløv, Denmark.
authors: Stephen T
authors: ST
authors: Buckley
authors: †Faculty of Pharmaceutical Sciences, Setsunan University, Osaka 573-0101, Japan.
authors: Shinji
authors: S
authors: Yamashita
mesh_terms: D000818:Animals; D001682:Biological Availability; D018938:Caco-2 Cells; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D007413:Intestinal Mucosa / Q000378:metabolism*; D054709:Lecithins / Q000737:chemistry; D008297:Male; D008320:Maltose / Q000031:analogs & derivatives* / Q000737:chemistry; D008823:Micelles; D010539:Permeability; D051381:Rats; D017207:Rats, Sprague-Dawley; D013501:Surface-Active Agents / Q000737:chemistry; D013656:Taurocholic Acid / Q000737:chemistry
chemical_list: D054709:Lecithins; D008823:Micelles; D013501:Surface-Active Agents; C459187:tetradecyl maltoside; D013656:Taurocholic Acid; D008320:Maltose
keywords: Caco-2; biorelevant media; in vitro−in vivo correlation (IVIVC); intestinal absorption; maltoside; permeation enhancement